loading
China Pharma Holdings Inc. stock is traded at $0.20, with a volume of 81,306. It is up +1.78% in the last 24 hours and down -14.89% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.1965
Open:
$0.1965
24h Volume:
81,306
Relative Volume:
0.22
Market Cap:
$3.78M
Revenue:
$7.78M
Net Income/Loss:
$-3.11M
P/E Ratio:
-0.4167
EPS:
-0.48
Net Cash Flow:
$-72,500
1W Performance:
+4.22%
1M Performance:
-14.89%
6M Performance:
-32.13%
1Y Performance:
-61.90%
1-Day Range:
Value
$0.1929
$0.20
1-Week Range:
Value
$0.1841
$0.205
52-Week Range:
Value
$0.17
$1.1575

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name
Name
China Pharma Holdings Inc.
Name
Phone
86 898 6681 1730
Name
Address
No. 17, Jinpan Road, Second Floor, Haikou
Name
Employee
276
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CPHI's Discussions on Twitter

Compare CPHI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CPHI
China Pharma Holdings Inc.
0.20 3.78M 7.78M -3.11M -72,500 -0.48
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-10 Initiated Rodman & Renshaw Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

pulisher
Nov 26, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Nov 26, 2024
pulisher
Nov 24, 2024

Stock market news : Feishang Anthracite Resources surges 49.48% as Shanghai Jiaoda Withub gains 34.62% - Business Upturn

Nov 24, 2024
pulisher
Nov 24, 2024

China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World

Nov 24, 2024
pulisher
Nov 23, 2024

China Resources Pharma Restructures for Industry Growth - MSN

Nov 23, 2024
pulisher
Nov 22, 2024

Layoff Tracker: Sonata Therapeutics Laying Off 20 Employees, Changing Leadership - BioSpace

Nov 22, 2024
pulisher
Nov 16, 2024

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World

Nov 16, 2024
pulisher
Nov 11, 2024

Biopharma Layoffs Roundup - Contract Pharma

Nov 11, 2024
pulisher
Nov 07, 2024

Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Pharma giant AstraZeneca says China chief detained - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Nov 07, 2024
pulisher
Nov 06, 2024

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network

Nov 05, 2024
pulisher
Nov 05, 2024

Exploring High Growth Tech Stocks Including Digital China Holdings And Two More - Yahoo Finance

Nov 05, 2024
pulisher
Nov 04, 2024

Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now? - Yahoo Finance

Nov 04, 2024
pulisher
Oct 30, 2024

AstraZeneca says its China operations president under investigation - Reuters

Oct 30, 2024
pulisher
Oct 29, 2024

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024
pulisher
Oct 24, 2024

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 - Yahoo Finance

Oct 24, 2024
pulisher
Oct 22, 2024

RRJ Buys $150 Million Luye Bonds, First China Deal Since 2019 - BNN Bloomberg

Oct 22, 2024
pulisher
Oct 21, 2024

Insiders of China Medical System Holdings Limited (HKG:867) must be disappointed as stock fell 4.7% after recent purchases - Simply Wall St

Oct 21, 2024
pulisher
Oct 21, 2024

AI Redefines the Pharmaceuticals Wholesale and Distribution Market, Projected to Grow by USD 896.5 Billion from 2024-2028, Boosting Global Sales - The Malaysian Reserve

Oct 21, 2024
pulisher
Oct 16, 2024

Several Insiders Invested In Mayne Pharma Group Flagging Positive News - Yahoo Finance Australia

Oct 16, 2024
pulisher
Oct 15, 2024

PDD Holdings Inc. (PDD): A Rising Star Among the Most Promising Chinese Stocks - Yahoo Finance

Oct 15, 2024
pulisher
Oct 13, 2024

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

China Constipation Treatment Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - IndiaPolitics.com

Oct 10, 2024
pulisher
Oct 09, 2024

China Pharma Holdings Inc. (CPHI) is a good investment, but the stock may be undervalued - US Post News

Oct 09, 2024
pulisher
Oct 08, 2024

The Psychology of China Pharma Holdings Inc. Inc. (CPHI) Price Performance: Understanding Market Sentiment - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

CK Life’s Yuen banks on Big Pharma experience to boost new drug success - South China Morning Post

Oct 08, 2024
pulisher
Oct 07, 2024

WuXi AppTec Falls 17% After $500 Million Convertible Bond Sale - BNN Bloomberg

Oct 07, 2024
pulisher
Oct 03, 2024

CPHI’s 52-Week Rollercoaster: From $0.17 to $1.21 – What’s Next for Investors? - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Analytical Overview: China Pharma Holdings Inc. (CPHI)’s Ratios Tell a Financial Story - The Dwinnex

Oct 03, 2024
pulisher
Oct 03, 2024

China's WuXi explores sale of pharma operations as US restrictions loom, FT reports - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

7 Best Chinese Stocks to Buy | Investing - U.S News & World Report Money

Oct 03, 2024
pulisher
Oct 01, 2024

Check out these key findings about China Pharma Holdings Inc. (CPHI) - SETE News

Oct 01, 2024
pulisher
Oct 01, 2024

PDD Holdings: China Stimulus Adds Rocket Fuel, Reiterate Buy - Seeking Alpha

Oct 01, 2024
pulisher
Sep 30, 2024

LEO Pharma announces Enstilar NDA submission for plaque psoriasis in China - Yahoo Finance

Sep 30, 2024
pulisher
Sep 30, 2024

Here's Why Yum China Holdings (YUMC) is a Strong Growth Stock - Yahoo Finance

Sep 30, 2024
pulisher
Sep 27, 2024

CPHI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 27, 2024
pulisher
Sep 27, 2024

LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China - Yahoo Finance

Sep 27, 2024
pulisher
Sep 24, 2024

China's Bold Stimulus Measures: What It Means for Markets - Saxo Bank

Sep 24, 2024
pulisher
Sep 23, 2024

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) - Yahoo Finance

Sep 23, 2024
pulisher
Sep 19, 2024

CSPC Pharma taps R&D superstar in quest for new breakout drugs - Bamboo Works

Sep 19, 2024
pulisher
Sep 14, 2024

Yum China Holdings, Inc. (YUMC): Analysts Are Bullish On This Undervalued Cyclical Stock Now - Yahoo Finance

Sep 14, 2024
pulisher
Sep 13, 2024

Investing in China Pharma Holdings Inc. (CPHI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

Sep 13, 2024
pulisher
Sep 12, 2024

China Pharma Holdings Inc.: Weathering Stock Market Storms with 4.04M Market Cap - The InvestChronicle

Sep 12, 2024
pulisher
Sep 11, 2024

Big pharma eyes China ‘at forefront of GLP-1 revolution’ - BioWorld Online

Sep 11, 2024
pulisher
Sep 10, 2024

US House Passes Bill to Blacklist Some China Biotech Firms - Yahoo Finance

Sep 10, 2024
pulisher
Sep 09, 2024

Summit’s checkpoint inhibitor trumps Keytruda in lung cancer trial - Clinical Trials Arena

Sep 09, 2024
pulisher
Sep 06, 2024

Plasma Fractionation Market Size to Expand Lucratively by 2031 - WhaTech

Sep 06, 2024
pulisher
Sep 06, 2024

Stocks to Watch, Sep 6: Glenmark Pharma, Godfrey, Max Fin Svcs, Pidilite - Business Standard

Sep 06, 2024
pulisher
Sep 05, 2024

AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities - Yahoo Finance

Sep 05, 2024

China Pharma Holdings Inc. Stock (CPHI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Cap:     |  Volume (24h):